Sugi Predict

Sugi Predict / Compounds / SCHEMBL29397483

SCHEMBL29397483

SCHEMBL29397483

CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CCC(=O)O)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O

nearest known ligand 0.68

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ BACE1 P56817 20/20 0.68
▸ CTSD P07339 2/20 0.66
▸ BACE2 Q9Y5Z0 5/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29394515 1.00 BACE1 (0.68) BACE1CTSDBACE2
SCHEMBL29397926 0.99 BACE1 (0.67) BACE1CTSDBACE2
SCHEMBL30175896 0.97 BACE1 (0.68) BACE1CTSDBACE2
SCHEMBL29396146 0.94 BACE1 (0.62) BACE1CTSDBACE2
SCHEMBL29397489 0.93 BACE1 (0.62) BACE1CTSDBACE2
SCHEMBL31257037 0.91 BACE1 (0.60) BACE1CTSDBACE2
SCHEMBL29486226 0.90 NPY4R (0.69) BACE1BACE2
SCHEMBL31672193 0.90 BACE1 (0.61) BACE1CTSDBACE2
SCHEMBL30436211 0.90 BACE1 (0.61) BACE1CTSDBACE2
SCHEMBL29616877 0.89 BACE1 (0.58) BACE1CTSDBACE2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4720107-A1 A FUSION PEPTIDE FOR ACTIVATION OF THE APJ AND / OR GLP-1 RECEPTORS University Of Ulster (GB) 2026-04-08 — — EP disclosed
WO-2024246015-A1 A FUSION PEPTIDE FOR ACTIVATION OF THE APJ AND / OR GLP-1 RECEPTORS UNIVERSITY OF ULSTER (GB) 2024-12-05 — — WO disclosed
EP-4196495-A1 EXENDIN-4 PEPTIDE ANALOGUES TXP Pharma GmbH (CH) 2023-06-21 — — EP disclosed
WO-2022034062-A1 EXENDIN-4 PEPTIDE ANALOGUES TXP PHARMA AG (CH) 2022-02-17 — — WO disclosed
Send feedback